Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.15 SEK | +3.17% | +9.81% | +36.80% |
May. 08 | Transcript : Orexo AB, Q1 2024 Earnings Call, May 08, 2024 | |
Apr. 17 | Orexo Expands, Extends US Patent for Nasal Anaphylaxis Treatment | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+36.80% | 68.05M | |
+10.23% | 8.96B | |
-10.76% | 5.19B | |
+51.58% | 4.77B | |
+12.50% | 4.26B | |
-20.70% | 2.37B | |
+12.83% | 2.3B | |
+19.51% | 2.17B | |
-29.65% | 2.21B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- ORX Stock
- News Orexo AB
- Transcript : Orexo AB, 2023 Earnings Call, Feb 08, 2024